We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
Turnover
15.26%
1-Year Est. Return
41.24%
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Cap. Flow
+$12.7B
Cap. Flow
% of AUM
18.75%
Top 10 Holdings %
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Avg Time Held
6.5
years
Top 10 Avg Time Held
5.9
years
Top 20 Avg Time Held
5.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$19.7B |
| 2 |
Walmart Inc
WMT
|
+$729M |
| 3 |
Kimberly-Clark
KMB
|
+$33.1M |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$799M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
Microsoft
MSFT
|
+$445M |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.2% |
| 2 | Technology | 23.92% |
| 3 | Consumer Staples | 7.59% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Communication Services | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1726
Utz Brands
UTZ
$1.27B
| $84.5K | ﹤0.01% |
10,674
-2,783
| -21% | -$25.9K |
2024 Q3
6 quarters
|
|
1727
Sabre
SABR
$722M
| $84K | ﹤0.01% |
57,940
-14,227
| -20% | -$18.9K |
2017 Q2
35 quarters
|
|
1728
Aquestive Therapeutics
AQST
$510M
| $84K | ﹤0.01% |
20,239
-4,243
| -17% | -$17.2K |
2024 Q3
6 quarters
|
|
1729
Rezolve AI
RZLV
$775M
| $82.4K | ﹤0.01% |
32,189
-493
| -2% | -$1.39K |
2025 Q2
3 quarters
|
|
1730
Ardagh Metal Packaging
AMBP
$2.79B
| $81.9K | ﹤0.01% |
20,224
-5,274
| -21% | -$23.4K |
2024 Q3
6 quarters
|
|
1731
Weave Communications
WEAV
$595M
| $81.8K | ﹤0.01% |
17,710
-904
| -5% | -$5.26K |
2024 Q4
5 quarters
|
|
1732
ReNew
RNW
$2.5B
| $81.4K | ﹤0.01% |
17,773
+2,542
| +17% | +$13.5K |
2025 Q4
1 quarter
|
|
1733
TPG RE Finance Trust
TRTX
$454M
| $81K | ﹤0.01% |
10,365
-1,963
| -16% | -$16.9K |
2024 Q3
6 quarters
|
|
1734
SunCoke Energy
SXC
$864M
| $80.2K | ﹤0.01% |
12,317
-4,198
| -25% | -$29.7K |
2020 Q2
23 quarters
|
|
1735
Prime Medicine
PRME
$655M
| $79.9K | ﹤0.01% |
22,968
-3,190
| -12% | -$12.1K |
2023 Q4
9 quarters
|
|
1736
Allogene Therapeutics
ALLO
$463M
| $79.6K | ﹤0.01% |
32,638
-5,396
| -14% | -$10.8K |
2019 Q4
25 quarters
|
|
1737
Cytek Biosciences
CTKB
$703M
| $79.6K | ﹤0.01% |
18,216
-4,517
| -20% | -$21.3K |
2022 Q1
16 quarters
|
|
1738
PagerDuty
PD
$1.36B
| $79.2K | ﹤0.01% |
12,753
-3,571
| -22% | -$30.9K |
2021 Q2
19 quarters
|
|
1739
RUM Group Inc
RUM
$2.46B
| $78.9K | ﹤0.01% |
15,471
-3,963
| -20% | -$22.8K |
2025 Q2
3 quarters
|
|
1740
FTAI Infrastructure
FIP
$303M
| $78.5K | ﹤0.01% |
15,892
-4,142
| -21% | -$23.2K |
2023 Q2
11 quarters
|
|
1741
Sweetgreen
SG
$1.26B
| $77.9K | ﹤0.01% |
15,013
-3,913
| -21% | -$23.8K |
2022 Q4
13 quarters
|
|
1742
Solid Power
SLDP
$486M
| $76.7K | ﹤0.01% |
25,551
-2,582
| -9% | -$10.4K |
2022 Q3
14 quarters
|
|
1743
Personalis
PSNL
$1.7B
| $76.1K | ﹤0.01% |
11,950
-1,131
| -9% | -$9.55K |
2025 Q2
3 quarters
|
|
1744
NioCorp Developments
NB
$475M
| $76K | ﹤0.01% |
17,042
-2,522
| -13% | -$14.5K |
2025 Q2
3 quarters
|
|
1745
Altimmune
ALT
$459M
| $75.5K | ﹤0.01% |
24,523
+3,707
| +18% | +$15.7K |
2024 Q3
6 quarters
|
|
1746
Vanda Pharmaceuticals
VNDA
$256M
| $74.2K | ﹤0.01% |
10,731
-2,058
| -16% | -$15.9K |
2013 Q2
51 quarters
|
|
1747
Lexeo Therapeutics
LXEO
$227M
| $73.8K | ﹤0.01% |
12,852
-1,900
| -13% | -$13.5K |
2025 Q4
1 quarter
|
|
1748
AMC Entertainment Holdings
AMC
$2.7B
| $73.4K | ﹤0.01% |
74,930
-19,548
| -21% | -$25.2K |
2024 Q3
6 quarters
|
|
1749
Atea Pharmaceuticals
AVIR
$363M
| $73.4K | ﹤0.01% |
13,638
-2,802
| -17% | -$12.9K |
2021 Q1
20 quarters
|
|
1750
ASP Isotopes
ASPI
$339M
| $72.8K | ﹤0.01% |
16,481
-423
| -3% | -$2.5K |
2024 Q4
5 quarters
|
|
Similar funds
ProShare Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 0.01% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.
- ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
- ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
- ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
- ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
- ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
- ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.